Binge eating disorder induced by venlafaxine and desvenlafaxine: A case report

Thales Pimenta de Figueiredo , Débora Marques de Miranda , Antônio Marcos Alvim-Soares Júnior , Miss Ana Clara Silva Melo Franco
{"title":"Binge eating disorder induced by venlafaxine and desvenlafaxine: A case report","authors":"Thales Pimenta de Figueiredo ,&nbsp;Débora Marques de Miranda ,&nbsp;Antônio Marcos Alvim-Soares Júnior ,&nbsp;Miss Ana Clara Silva Melo Franco","doi":"10.1016/j.dscb.2025.100216","DOIUrl":null,"url":null,"abstract":"<div><div>This case report discusses an unmarried female in her middle-thirties with a history of Recurrent Depressive Disorder. After taking both venlafaxine and desvenlafaxine, she began to show symptoms of Binge Eating Disorder. To alleviate these symptoms, she discontinued the medications and switched to bupropion, which helped her overcome the eating-related issues. However, her depressive symptoms then returned. The report examines how serotonin and norepinephrine reuptake inhibitors work, which may explain the observer phenomenon and clarify the eating behaviors in this case that might initially appear paradoxical. Moreover, it suggests clinicians close monitor outcomes when using such medications, as symptoms worsening might be an adverse effect rather than a disease progression. A diagrammatic timeline of the case report can be observed in <span><span>Fig. 1</span></span>.</div></div>","PeriodicalId":72447,"journal":{"name":"Brain disorders (Amsterdam, Netherlands)","volume":"18 ","pages":"Article 100216"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain disorders (Amsterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666459325000368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This case report discusses an unmarried female in her middle-thirties with a history of Recurrent Depressive Disorder. After taking both venlafaxine and desvenlafaxine, she began to show symptoms of Binge Eating Disorder. To alleviate these symptoms, she discontinued the medications and switched to bupropion, which helped her overcome the eating-related issues. However, her depressive symptoms then returned. The report examines how serotonin and norepinephrine reuptake inhibitors work, which may explain the observer phenomenon and clarify the eating behaviors in this case that might initially appear paradoxical. Moreover, it suggests clinicians close monitor outcomes when using such medications, as symptoms worsening might be an adverse effect rather than a disease progression. A diagrammatic timeline of the case report can be observed in Fig. 1.
文拉法辛与地文拉法辛致暴食症1例
本病例报告讨论了一位35岁左右的未婚女性,有复发性抑郁症的病史。同时服用文拉法辛和地文拉法辛后,她开始出现暴食症的症状。为了缓解这些症状,她停止了药物治疗,转而服用安非他酮,这帮助她克服了与饮食有关的问题。然而,她的抑郁症状随后又出现了。该报告研究了血清素和去甲肾上腺素再摄取抑制剂是如何起作用的,这可能解释了观察者的现象,并澄清了在这种情况下最初看似矛盾的饮食行为。此外,它建议临床医生在使用此类药物时密切监测结果,因为症状恶化可能是不良反应,而不是疾病进展。在图1中可以观察到病例报告的图表时间表。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Brain disorders (Amsterdam, Netherlands)
Brain disorders (Amsterdam, Netherlands) Neurology, Clinical Neurology
CiteScore
1.90
自引率
0.00%
发文量
0
审稿时长
51 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信